Clinical Trials Directory

Trials / Completed

CompletedNCT03948750

Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis

Comparison of Immunoblotting (IgA and IgG) and the Goldmann-Witmer Coefficient for Diagnosis of Ocular Toxoplasmosis in Immunocompetent Patients

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of OT is based on clinical findings, but in most cases, laboratory tests are required to confirm the etiology, especially when other diseases are suspected. The aim of this study was to evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB) with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose OT, in current practice, especially in the first three weeks.

Detailed description

Goldmann-Witmer coefficient (GWC): compares the levels of intraocular antibody (igG) production to that serum, as measured by ELISA. GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in aqueous humour/Total IgG in serum) 0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody production, \> 4: Diagnostic of intraocular antibody production to a specific microbial pathogen

Conditions

Interventions

TypeNameDescription
PROCEDUREAqueous humour samplingAqueous humour sampling with Goldman-Witmer coefficient and immunoblotting

Timeline

Start date
2010-01-01
Primary completion
2014-05-31
Completion
2014-05-31
First posted
2019-05-14
Last updated
2019-05-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03948750. Inclusion in this directory is not an endorsement.